(19)
(11) EP 0 711 344 A1

(12)

(43) Date of publication:
15.05.1996 Bulletin 1996/20

(21) Application number: 94920557.0

(22) Date of filing: 13.07.1994
(51) International Patent Classification (IPC): 
A01K 67/ 027( . )
A23J 3/ 08( . )
A61K 38/ 00( . )
C07K 14/ 76( . )
C12N 15/ 09( . )
C12N 15/ 85( . )
C12R 1/ 91( . )
A23J 1/ 20( . )
A23L 1/ 305( . )
A61P 3/ 00( . )
C12N 5/ 10( . )
C12N 15/ 12( . )
C12P 21/ 02( . )
(86) International application number:
PCT/GB1994/001514
(87) International publication number:
WO 1995/002692 (26.01.1995 Gazette 1995/05)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 16.07.1993 GB 19930014802

(71) Applicant: PPL Therapeutics (Scotland) Limited
Edinburgh, Midlothian EH25 9PP (GB)

(72) Inventors:
  • COLMAN, Alan
    Coventry CV4 8AQ (GB)
  • WRIGHT, Gordon
    Midlothian EH26 8DQ (GB)
  • SAWYER, Lindsay
    Edinburgh EH10 5HB (GB)
  • RIGDEN, Daniel John
    Cheshire CW2 7PX (GB)

(74) Representative: Chapman, Paul William, et al 
Kilburn & Strode, 30 John Street
London WC1N 2DD
London WC1N 2DD (GB)

   


(54) MODIFIED ALPHA-LACTALBUMIN